Evaluation – Sebia Canada – Industry Workshop – I061600-B Session Title: Immunotyping Electrophoresis: Performance and Practicalities Presenters: David Grenache, PhD, MT(ASCP), D(ABCC), FAACC, Chief Scientific Officer, TriCore Reference Laboratories Katie Thoren, PhD, D(ABCC), FAACC, Associate Professor, Director of Advanced Protein Diagnostics Laboratory, University of Miami Objectives: At the conclusion of this session, participants will be able to explain and apply: Discuss the advantages and limitations of IT and IF in detecting monoclonal proteins Describe how an IT training program can improve IT interpretation skills Describe how IT can be used in combination with other assays to screen and monitor monoclonal gammopathies List practical advantages of IT over IF 1. Please rate the Session by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly AgreeSufficient time was allowed for audience participation/active learning. One Two Three Four Five The facilities were satisfactory. One Two Three Four Five The session was free from commercial bias. One Two Three Four Five Overall, I would rate this Symposium as excellent. One Two Three Four Five 2. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Bonnie Cheung, Sebia CanadaClarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please assess the Speaker by choosing the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree David Grenache, PhD, MT(ASCP), D(ABCC), FAACC, Chief Scientific Officer, TriCore Reference Laboratories Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 3. Please asses the Speaker by circling the appropriate number. Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree Katie Thoren, PhD, D(ABCC), FAACC, Associate Professor, Director of Advanced Protein Diagnostics Laboratory, University of Miami Clarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 4. As a result of attending this session, I am planning to: (please check one)a) Discuss the session with my colleagues Yes No b) Pursue additional learning activities. Yes No c) Complete a Personal Learning Project. Yes No d) Not change my practice. Yes No 3) Change my practice. Yes No 5. Please explain the change you are planning to make or the learning you plan to complete:6. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply) Medical Expert Communicator Collaborator Manager Health Advocate Scholar Professional 7. General comments about individual speakers8. What topics need to be addressed at future conferences to keep you up to date in your profession?Name Session Title Date Year Location Conference/Event CreditsEmail Session Code
